Best rated oncology clinic for cancer treatment: A comparative evidence review

The search for the best rated oncology clinic for cancer treatment requires more than a single leaderboard. Available research identifies major centers in the United States, Europe, Asia, and Israel, while also showing that rankings measure different combinations of reputation, outcomes, accreditation, research, patient reports, and specialty expertise.

How oncology clinic ratings are determined

U.S. News & World Report rankings commonly evaluate factors associated with cancer care, including patient outcomes, clinical expertise, nurse staffing, and participation in peer-reviewed research. The National Cancer Institute also maintains a database of NCI-designated cancer centers, which receive federal recognition for meeting rigorous research and clinical-care standards. These measures can help distinguish comprehensive institutions from clinics assessed mainly through patient reviews or local physician recognition. 11

International systems use different methodologies. Newsweek’s specialized-hospital assessments can combine recommendations from healthcare professionals, professional accreditations, and patient-reported outcomes. The Asia-Pacific assessment involving Samsung Medical Center used reputation surveys across 11 countries, national medical accreditation, and patient-reported outcome measures. Because the criteria differ, a first-place result in one system does not automatically mean that a center is the best match for every diagnosis. 6

Leading U.S. cancer centers

UT MD Anderson Cancer Center was named the No. 1 hospital in the United States for cancer care in the 2026-2027 U.S. News survey, according to the institution’s reported ranking. The center stated that it had maintained the top position for 12 consecutive years and had remained among the nation’s top two cancer hospitals since the survey began in 1990. It also received high-performing ratings for leukemia, lymphoma and myeloma treatment, lung cancer surgery, prostate cancer surgery, and other procedures. 1

Memorial Sloan Kettering Cancer Center reported a No. 2 national position for cancer care in the same U.S. News listing and recognition as the leading cancer center in the Northeast. Its 2025 honors report also described recognition among the world’s leading oncology centers, while noting Magnet designation for nursing for the third time. Other widely recognized U.S. institutions include Mayo Clinic, Dana-Farber, Johns Hopkins, Cleveland Clinic, Northwestern Medicine, UCLA Jonsson Comprehensive Cancer Center, and UPMC Hillman Cancer Center. 2

International centers with prominent oncology recognition

Sheba Medical Center’s Jusidman Cancer Center is described as Israel’s largest and most comprehensive oncology center, treating approximately 50,000 cancer patients annually across stages of diagnosis and treatment. The center reports a formal relationship with UT MD Anderson that includes faculty exchanges, shared research programs, and collaborative clinical development. Sheba has also been recognized by Newsweek as one of the world’s best specialized oncology hospitals. 3

Samsung Medical Center was named the leading hospital for oncology in Newsweek’s Best Specialized Hospitals Asia Pacific 2026 assessment. The report said Samsung ranked No. 1 in oncology for the third consecutive year since 2024, based on professional reputation, accreditation status, and patient-reported outcomes. In Spain, the Clínic Barcelona Comprehensive Cancer Centre received Organisation of European Cancer Institutes accreditation as a Comprehensive Cancer Centre, recognizing integration of care, research, education, innovation, and precision oncology. 5 6

Specialty and physician-level distinctions

A cancer center’s overall position may be less relevant than its expertise in a particular malignancy. MD Anderson received high-performing ratings for several cancer-related surgeries and blood-cancer treatments, while Memorial Sloan Kettering reported the No. 1 national ranking for urology. UCSF physician Madhav R. Seshadri specializes in Hodgkin lymphoma, non-Hodgkin lymphoma, and chronic lymphocytic leukemia, with experience in stem-cell transplantation, targeted therapy, immunotherapy, and CAR T-cell treatment. 1 2 10

Individual physician ratings can provide a patient-experience signal, but they are not equivalent to institutional cancer outcomes. A Mass General Brigham profile for medical oncologist Ryan J. Sullivan listed a 5.0 rating from 131 ratings and 66 reviews, along with board certification in medical oncology. The profile also showed multiple accepted insurance plans, but explicitly advised patients to verify coverage with the practice. This illustrates why clinician fit, subspecialty, treatment setting, and coverage should be assessed together. 8

Research, precision medicine, and clinical trials

Leading oncology institutions commonly combine treatment with research and education. HM CIOCC in Spain describes its model as integrating prevention, early diagnosis, advanced treatment, molecular medicine, and clinical investigation. The center reports more than 381 clinical trials each year and more than 40,000 consultations annually. Such figures indicate research capacity, but they do not establish that every trial is suitable for every patient or cancer type. Eligibility depends on the study protocol and clinical circumstances. 9

Precision oncology uses tumor-genetic profiling or molecular testing to help tailor treatment strategies. Calaway-Young Cancer Center in Colorado reports using tumor-genetic profiling, advanced radiation technologies, and more than 120 therapeutic agents, while holding accreditation from the American College of Surgeons Commission on Cancer. These details demonstrate the range of services that can exist outside globally ranked academic hospitals, although accreditation, available specialists, and treatment scope should be reviewed for the specific diagnosis. 7

Practical limitations when comparing clinics

Rankings are not personalized medical recommendations. A center may rank highly overall yet lack the most relevant expertise, trial, pediatric service, transplant program, or surgical specialization for a particular case. International treatment can also involve travel, language, records transfer, continuity between visits, and coordination with local clinicians. These factors can create practical friction even when a hospital has strong research credentials or international recognition.

Patients comparing oncology clinics should examine the cancer type treated, relevant subspecialists, multidisciplinary review, diagnostic and molecular capabilities, clinical-trial eligibility, accreditation, reported patient outcomes, nursing support, follow-up arrangements, and insurance participation. Coverage is not uniform, and provider directories may be incomplete, as illustrated by the Mass General Brigham profile’s instruction to confirm accepted plans. A second medical opinion can clarify whether a highly ranked institution offers a meaningful advantage for the individual diagnosis. 8

What a balanced comparison should conclude

Current research supports describing MD Anderson and Memorial Sloan Kettering as leading U.S. cancer centers, with MD Anderson holding the reported 2026-2027 U.S. News No. 1 position and MSK holding the reported No. 2 position. Sheba, Samsung Medical Center, Clínic Barcelona, HM CIOCC, UCSF, Mass General Brigham, and accredited regional centers represent additional models of comprehensive, specialty-focused, research-oriented, or community-based oncology care. 1 2 3 5 6 7 8 9 10

The most defensible answer to “best rated” is therefore conditional rather than universal. Institutional ranking is one screening tool, while diagnosis-specific expertise, evidence-based treatment options, clinical-trial access, accreditation, logistics, coverage, and long-term follow-up determine practical suitability. Ratings should inform questions for an oncology team, not replace individualized medical advice or independent review of treatment risks and alternatives.

Sources

1. UT MD Anderson Cancer Center, “UT MD Anderson ranks No. 1 in the nation for cancer care for 12th year in a row”
2. Memorial Sloan Kettering Cancer Center, “MSK Honors in 2025”
3. Sheba Medical Center, “Cancer care without compromise”
4. Virginia Cancer Specialists, “Named #1 practice in Virginia for cancer care”
5. Hospital Clínic Barcelona, “Cancer Centre obtains OECI accreditation”
6. The Bio News, “Samsung Medical Center named Asia-Pacific’s top hospital for cancer”
7. Calaway-Young Cancer Center, Valley View Hospital
8. Mass General Brigham, Ryan J. Sullivan, MD provider profile
9. HM CIOCC, “About Us”
10. UCSF Health, Madhav R. Seshadri, MD provider profile
11. National Cancer Institute, NCI-designated cancer centers information